Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Bezard, E; Brotchie, JM; Gross, CE
   Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
   NATURE REVIEWS NEUROSCIENCE
   
   E. Bezard et al., "Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies", NAT REV NEU, 2(8), 2001, pp. 577-588
2. Beal, MF
   Experimental models of Parkinson's disease
   NATURE REVIEWS NEUROSCIENCE
   
   M.F. Beal, "Experimental models of Parkinson's disease", NAT REV NEU, 2(5), 2001, pp. 325-332
3. Cumming, P; Munk, OL; Doudet, D
   Loss of metabolites from monkey striatum during PET with FDOPA
   SYNAPSE
   
   P. Cumming et al., "Loss of metabolites from monkey striatum during PET with FDOPA", SYNAPSE, 41(3), 2001, pp. 212-218
4. Rothblat, DS; Schroeder, JA; Schneider, JS
   Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: Potential contributors to spontaneous recovery from experimental Parkinsonism
   JOURNAL OF NEUROSCIENCE RESEARCH
   
   D.S. Rothblat et al., "Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: Potential contributors to spontaneous recovery from experimental Parkinsonism", J NEUROSC R, 65(3), 2001, pp. 254-266
5. Bezard, E; Dovero, S; Prunier, C; Ravenscroft, P; Chalon, S; Guilloteau, D; Crossman, AR; Bioulac, B; Brotchie, JM; Gross, CE
   Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease
   JOURNAL OF NEUROSCIENCE
   
   E. Bezard et al., "Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease", J NEUROSC, 21(17), 2001, pp. 6853-6861
6. Hurley, MJ; Mash, DC; Jenner, P
   Dopamine D-1 receptor expression in human basal ganglia and changes in Parkinson's disease
   MOLECULAR BRAIN RESEARCH
   
   M.J. Hurley et al., "Dopamine D-1 receptor expression in human basal ganglia and changes in Parkinson's disease", MOL BRAIN R, 87(2), 2001, pp. 271-279
7. Olanow, CW; Watts, RL; Koller, WC
   An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines
   NEUROLOGY
   
   C.W. Olanow et al., "An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines", NEUROLOGY, 56(11), 2001, pp. S1-S88
8. Levy, R; Dostrovsky, JO; Lang, AE; Sime, E; Hutchison, WD; Lozano, AM
   Effects of apomorphine on subthalamic nucleus and globus pallidus internusneurons in patients with Parkinson's disease
   JOURNAL OF NEUROPHYSIOLOGY
   
   R. Levy et al., "Effects of apomorphine on subthalamic nucleus and globus pallidus internusneurons in patients with Parkinson's disease", J NEUROPHYS, 86(1), 2001, pp. 249-260
9. Wichmann, T; Kliem, MA; DeLong, MR
   Antiparkinsonian and behavioral effects of inactivation of the substantia nigra pars reticulata in hemiparkinsonian primates
   EXPERIMENTAL NEUROLOGY
   
   T. Wichmann et al., "Antiparkinsonian and behavioral effects of inactivation of the substantia nigra pars reticulata in hemiparkinsonian primates", EXP NEUROL, 167(2), 2001, pp. 410-424
10. Guridi, J; Obeso, JA
    The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma
    BRAIN
    
    J. Guridi e J.A. Obeso, "The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma", BRAIN, 124, 2001, pp. 5-19
11. Howell, LL; Byrd, LD; McDonough, AM; Iuvone, PM; Bakay, RAE
    Behavioral evaluation of hemiparkinsonian MPTP monkeys following dopamine pharmacological manipulation and adrenal co-graft transplantation
    CELL TRANSPLANTATION
    
    L.L. Howell et al., "Behavioral evaluation of hemiparkinsonian MPTP monkeys following dopamine pharmacological manipulation and adrenal co-graft transplantation", CELL TRANSP, 9(5), 2000, pp. 609-622
12. Benazzouz, A; Piallat, B; Ni, ZG; Koudsie, A; Pollak, P; Benabid, AL
    Implication of the subthalamic nucleus in the pathophysiology and pathogenesis of Parkinson's disease
    CELL TRANSPLANTATION
    
    A. Benazzouz et al., "Implication of the subthalamic nucleus in the pathophysiology and pathogenesis of Parkinson's disease", CELL TRANSP, 9(2), 2000, pp. 215-221
13. Mandir, AS; Vaughan, C
    Pathophysiology of Parkinson's disease
    INTERNATIONAL REVIEW OF PSYCHIATRY
    
    A.S. Mandir e C. Vaughan, "Pathophysiology of Parkinson's disease", INT R PSYC, 12(4), 2000, pp. 270-280
14. Doudet, DJ; Holden, JE; Jivan, S; McGeer, E; Wyatt, RJ
    In vivo PET studies of the dopamine D2 receptors in rhesus monkeys with long-term MPTP-induced parkinsonism
    SYNAPSE
    
    D.J. Doudet et al., "In vivo PET studies of the dopamine D2 receptors in rhesus monkeys with long-term MPTP-induced parkinsonism", SYNAPSE, 38(2), 2000, pp. 105-113
15. Pope-Coleman, K; Tinker, JP; Schneider, JS
    Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergicmarkers in the striatum of parkinsonian monkeys
    SYNAPSE
    
    K. Pope-Coleman et al., "Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergicmarkers in the striatum of parkinsonian monkeys", SYNAPSE, 36(2), 2000, pp. 120-128
16. Filion, M
    Physiologic basis of dyskinesia
    ANNALS OF NEUROLOGY
    
    M. Filion, "Physiologic basis of dyskinesia", ANN NEUROL, 47(4), 2000, pp. S35-S41
17. Calon, F; Grondin, R; Morissette, M; Goulet, M; Blanchet, PJ; Di Paolo, T; Bedard, PJ
    Molecular basis of levodopa-induced dyskinesias
    ANNALS OF NEUROLOGY
    
    F. Calon et al., "Molecular basis of levodopa-induced dyskinesias", ANN NEUROL, 47(4), 2000, pp. S70-S78
18. Vitek, JL; Giroux, M
    Physiology of hypokinetic and hyperkinetic movement disorders: Model for dyskinesia
    ANNALS OF NEUROLOGY
    
    J.L. Vitek e M. Giroux, "Physiology of hypokinetic and hyperkinetic movement disorders: Model for dyskinesia", ANN NEUROL, 47(4), 2000, pp. S131-S140
19. Lozano, AM; Lang, AE; Levy, R; Hutchison, W; Dostrovsky, J
    Neuronal recordings in Parkinson's disease Patients with dyskinesias induced by apomorphine
    ANNALS OF NEUROLOGY
    
    A.M. Lozano et al., "Neuronal recordings in Parkinson's disease Patients with dyskinesias induced by apomorphine", ANN NEUROL, 47(4), 2000, pp. S141-S146
20. Olanow, CW; Obeso, JA
    Preventing levodopa-induced dyskinesias
    ANNALS OF NEUROLOGY
    
    C.W. Olanow e J.A. Obeso, "Preventing levodopa-induced dyskinesias", ANN NEUROL, 47(4), 2000, pp. S167-S178
21. Marini, AM; Nowak, TS
    Metabolic effects of 1-methyl-4-phenylpyridinium (MPP+) in primary neuron cultures
    JOURNAL OF NEUROSCIENCE RESEARCH
    
    A.M. Marini e T.S. Nowak, "Metabolic effects of 1-methyl-4-phenylpyridinium (MPP+) in primary neuron cultures", J NEUROSC R, 62(6), 2000, pp. 814-820
22. Chadha, A; Dawson, LG; Jenner, PG; Duty, S
    Effect of unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway on GABA(A) receptor subunit gene expression in the rodent basal ganglia and thalamus
    NEUROSCIENCE
    
    A. Chadha et al., "Effect of unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway on GABA(A) receptor subunit gene expression in the rodent basal ganglia and thalamus", NEUROSCIENC, 95(1), 2000, pp. 119-126
23. Ochi, M; Koga, K; Kurokawa, M; Kase, H; Nakamura, J; Kuwana, Y
    Systemic administration of adenosine A(2A) receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: A microdialysis study
    NEUROSCIENCE
    
    M. Ochi et al., "Systemic administration of adenosine A(2A) receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: A microdialysis study", NEUROSCIENC, 100(1), 2000, pp. 53-62
24. Raz, A; Vaadia, E; Bergman, H
    Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism
    JOURNAL OF NEUROSCIENCE
    
    A. Raz et al., "Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism", J NEUROSC, 20(22), 2000, pp. 8559-8571
25. Nash, JE; Brotchie, JM
    A common signaling pathway for striatal NMDA and adenosine A(2a) receptors: Implications for the treatment of Parkinson's disease
    JOURNAL OF NEUROSCIENCE
    
    J.E. Nash e J.M. Brotchie, "A common signaling pathway for striatal NMDA and adenosine A(2a) receptors: Implications for the treatment of Parkinson's disease", J NEUROSC, 20(20), 2000, pp. 7782-7789
26. Obeso, JA; Rodriguez-Oroz, MC; Rodriguez, M; Lanciego, JL; Artieda, J; Gonzalo, N; Olanow, CW
    Pathophysiology of the basal ganglia in Parkinson's disease
    TRENDS IN NEUROSCIENCES
    
    J.A. Obeso et al., "Pathophysiology of the basal ganglia in Parkinson's disease", TRENDS NEUR, 23(10), 2000, pp. S8-S19
27. Olanow, CW; Schapira, AHV; Rascol, O
    Continuous dopamine-receptor stimulation in early Parkinson's disease
    TRENDS IN NEUROSCIENCES
    
    C.W. Olanow et al., "Continuous dopamine-receptor stimulation in early Parkinson's disease", TRENDS NEUR, 23(10), 2000, pp. S117-S126
28. Hikosaka, O; Takikawa, Y; Kawagoe, R
    Role of the basal ganglia in the control of purposive saccadic eye movements
    PHYSIOLOGICAL REVIEWS
    
    O. Hikosaka et al., "Role of the basal ganglia in the control of purposive saccadic eye movements", PHYSIOL REV, 80(3), 2000, pp. 953-978
29. Goulet, M; Madras, BK
    D-1 dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    M. Goulet e B.K. Madras, "D-1 dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys", J PHARM EXP, 292(2), 2000, pp. 714-724
30. Crossman, AR
    Functional anatomy of movement disorders
    JOURNAL OF ANATOMY
    
    A.R. Crossman, "Functional anatomy of movement disorders", J ANAT, 196, 2000, pp. 519-525
31. Jellinger, KA
    The role of iron in neurodegeneration - Prospects for pharmacotherapy of Parkinson's disease
    DRUGS & AGING
    
    K.A. Jellinger, "The role of iron in neurodegeneration - Prospects for pharmacotherapy of Parkinson's disease", DRUG AGING, 14(2), 1999, pp. 115-140
32. Bezard, E; Boraud, T; Bioulac, B; Gross, CE
    Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms
    EUROPEAN JOURNAL OF NEUROSCIENCE
    
    E. Bezard et al., "Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms", EUR J NEURO, 11(6), 1999, pp. 2167-2170
33. Stefani, A; Spadoni, F; Giacomini, P; Lavaroni, F; Bernardi, G
    The modulation of calcium current by GABA metabotropic receptors in a sub-population of pallidal neurons
    EUROPEAN JOURNAL OF NEUROSCIENCE
    
    A. Stefani et al., "The modulation of calcium current by GABA metabotropic receptors in a sub-population of pallidal neurons", EUR J NEURO, 11(11), 1999, pp. 3995-4005
34. Kupsch, A; Earl, C
    Neurosurgical interventions in the treatment of idiopathic Parkinson disease: neurostimulation and neural implantation
    JOURNAL OF MOLECULAR MEDICINE-JMM
    
    A. Kupsch e C. Earl, "Neurosurgical interventions in the treatment of idiopathic Parkinson disease: neurostimulation and neural implantation", J MOL MED-J, 77(1), 1999, pp. 178-184
35. Wilms, H; Sievers, J; Deuschl, G
    Animal models of tremor
    MOVEMENT DISORDERS
    
    H. Wilms et al., "Animal models of tremor", MOVEMENT D, 14(4), 1999, pp. 557-571
36. Brownell, AL; Jenkins, BG; Isacson, O
    Dopamine imaging markers and predictive mathematical models for progressive degeneration in Parkinson's disease
    BIOMEDICINE & PHARMACOTHERAPY
    
    A.L. Brownell et al., "Dopamine imaging markers and predictive mathematical models for progressive degeneration in Parkinson's disease", BIOMED PHAR, 53(3), 1999, pp. 131-140
37. Duan, WZ; Zhang, ZM; Gash, DM; Mattson, MP
    Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease
    ANNALS OF NEUROLOGY
    
    W.Z. Duan et al., "Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease", ANN NEUROL, 46(4), 1999, pp. 587-597
38. Vitek, JL; Chockkan, V; Zhang, JY; Kaneoke, Y; Evatt, M; DeLong, MR; Triche, S; Mewes, K; Hashimoto, T; Bakay, RAE
    Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus
    ANNALS OF NEUROLOGY
    
    J.L. Vitek et al., "Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus", ANN NEUROL, 46(1), 1999, pp. 22-35
39. Gross, CE; Boraud, T; Guehl, D; Bioulac, B; Bezard, E
    From experimentation to the surgical treatment of Parkinson's disease: Prelude or suite in basal ganglia research?
    PROGRESS IN NEUROBIOLOGY
    
    C.E. Gross et al., "From experimentation to the surgical treatment of Parkinson's disease: Prelude or suite in basal ganglia research?", PROG NEUROB, 59(5), 1999, pp. 509-532
40. Doudet, DJ; Chan, GLY; Jivan, S; DeJesus, OT; McGeer, EG; English, C; Ruth, TJ; Holden, JE
    Evaluation of dopaminergic presynaptic integrity: 6-[F-18]fluoro-L-dopa versus 6-[F-18]fluoro-L-m-tyrosine
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    
    D.J. Doudet et al., "Evaluation of dopaminergic presynaptic integrity: 6-[F-18]fluoro-L-dopa versus 6-[F-18]fluoro-L-m-tyrosine", J CEREBR B, 19(3), 1999, pp. 278-287
41. Stanford, IM; Cooper, AJ
    Presynaptic mu and delta opioid receptor modulation of GABA(A) IPSCs in the rat globus pallidus in vitro
    JOURNAL OF NEUROSCIENCE
    
    I.M. Stanford e A.J. Cooper, "Presynaptic mu and delta opioid receptor modulation of GABA(A) IPSCs in the rat globus pallidus in vitro", J NEUROSC, 19(12), 1999, pp. 4796-4803
42. Tolwani, RJ; Jakowec, MW; Petzinger, GM; Green, S; Waggie, K
    Experimental models of Parkinson's disease: Insights from many models
    LABORATORY ANIMAL SCIENCE
    
    R.J. Tolwani et al., "Experimental models of Parkinson's disease: Insights from many models", LAB ANIM SC, 49(4), 1999, pp. 363-371
43. Khudados, E; Cody, FWJ; O'Boyle, DJ
    Proprioceptive regulation of voluntary ankle movements, demonstrated usingmuscle vibration, is impaired by Parkinson's disease
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    
    E. Khudados et al., "Proprioceptive regulation of voluntary ankle movements, demonstrated usingmuscle vibration, is impaired by Parkinson's disease", J NE NE PSY, 67(4), 1999, pp. 504-510
44. LOZANO AM; LANG AE
    PALLIDOTOMY FOR PARKINSONS-DISEASE
    Neurosurgery clinics of North America
    
    A.M. Lozano e A.E. Lang, "PALLIDOTOMY FOR PARKINSONS-DISEASE", Neurosurgery clinics of North America, 9(2), 1998, pp. 325
45. BEZARD E; BORAUD T; IMBERT C; DOVERO S; BIOULAC B; GROSS CE
    TOWARDS A DYNAMIC APPROACH OF EXPERIMENTAL PARKINSONISM
    Progress in neuro-psychopharmacology & biological psychiatry
    
    E. Bezard et al., "TOWARDS A DYNAMIC APPROACH OF EXPERIMENTAL PARKINSONISM", Progress in neuro-psychopharmacology & biological psychiatry, 22(8), 1998, pp. 1317-1329
46. BERGMAN H; FEINGOLD A; NINI A; RAZ A; SLOVIN H; ABELES M; VAADIA E
    PHYSIOLOGICAL-ASPECTS OF INFORMATION-PROCESSING IN THE BASAL GANGLIA OF NORMAL AND PARKINSONIAN PRIMATES
    Trends in neurosciences
    
    H. Bergman et al., "PHYSIOLOGICAL-ASPECTS OF INFORMATION-PROCESSING IN THE BASAL GANGLIA OF NORMAL AND PARKINSONIAN PRIMATES", Trends in neurosciences, 21(1), 1998, pp. 32-38
47. PFANN KD; PENN RD; SHANNON KM; CORCOS DM
    PALLIDOTOMY AND BRADYKINESIA - IMPLICATIONS FOR BASAL GANGLIA FUNCTION
    Neurology
    
    K.D. Pfann et al., "PALLIDOTOMY AND BRADYKINESIA - IMPLICATIONS FOR BASAL GANGLIA FUNCTION", Neurology, 51(3), 1998, pp. 796-803
48. ROTHBLAT DS; SCHNEIDER JS
    THE EFFECTS OF L-DEPRENYL TREATMENT, ALONE AND COMBINED WITH GM1 GANGLIOSIDE, ON STRIATAL DOPAMINE CONTENT AND SUBSTANTIA-NIGRA PARS COMPACTA NEURONS
    Brain research
    
    D.S. Rothblat e J.S. Schneider, "THE EFFECTS OF L-DEPRENYL TREATMENT, ALONE AND COMBINED WITH GM1 GANGLIOSIDE, ON STRIATAL DOPAMINE CONTENT AND SUBSTANTIA-NIGRA PARS COMPACTA NEURONS", Brain research, 779(1-2), 1998, pp. 226-230
49. JENNER PG
    IS STIMULATION OF D-1 AND D-2 DOPAMINE-RECEPTORS IMPORTANT FOR OPTIMAL MOTOR FUNCTIONING IN PARKINSONS-DISEASE
    European journal of neurology
    
    P.G. Jenner, "IS STIMULATION OF D-1 AND D-2 DOPAMINE-RECEPTORS IMPORTANT FOR OPTIMAL MOTOR FUNCTIONING IN PARKINSONS-DISEASE", European journal of neurology, 4, 1997, pp. 3-11
50. SCHAPIRA AHV
    PATHOGENESIS OF PARKINSONS-DISEASE
    Bailliere's clinical neurology
    
    A.H.V. Schapira, "PATHOGENESIS OF PARKINSONS-DISEASE", Bailliere's clinical neurology, 6(1), 1997, pp. 15-36
51. EBERLING JL; BANKIEWICZ KS; JORDAN S; VANBROCKLIN HF; JAGUST WJ
    PET STUDIES OF FUNCTIONAL COMPENSATION IN A PRIMATE MODEL OF PARKINSONS-DISEASE
    NeuroReport
    
    J.L. Eberling et al., "PET STUDIES OF FUNCTIONAL COMPENSATION IN A PRIMATE MODEL OF PARKINSONS-DISEASE", NeuroReport, 8(12), 1997, pp. 2727-2733
52. MURER MG; RIQUELME LA; TSENG KY; PAZO JH
    SUBSTANTIA-NIGRA PARS RETICULATA SINGLE-UNIT ACTIVITY IN NORMAL AND 60HDA-LESIONED RATS - EFFECTS OF INTRASTRIATAL APOMORPHINE AND SUBTHALAMIC LESIONS
    Synapse
    
    M.G. Murer et al., "SUBSTANTIA-NIGRA PARS RETICULATA SINGLE-UNIT ACTIVITY IN NORMAL AND 60HDA-LESIONED RATS - EFFECTS OF INTRASTRIATAL APOMORPHINE AND SUBTHALAMIC LESIONS", Synapse, 27(4), 1997, pp. 278-293
53. RIOUX L; FROHNA PA; JOYCE JN; SCHNEIDER JS
    THE EFFECTS OF CHRONIC LEVODOPA TREATMENT ON PRESYNAPTIC AND POSTSYNAPTIC MARKERS OF DOPAMINERGIC FUNCTION IN STRIATUM OF PARKINSONIAN MONKEYS
    Movement disorders
    
    L. Rioux et al., "THE EFFECTS OF CHRONIC LEVODOPA TREATMENT ON PRESYNAPTIC AND POSTSYNAPTIC MARKERS OF DOPAMINERGIC FUNCTION IN STRIATUM OF PARKINSONIAN MONKEYS", Movement disorders, 12(2), 1997, pp. 148-158
54. HUTCHISON WD; LEVY R; DOSTROVSKY JO; LOZANO AM; LANG AE
    EFFECTS OF APOMORPHINE ON GLOBUS-PALLIDUS NEURONS IN PARKINSONIAN-PATIENTS
    Annals of neurology
    
    W.D. Hutchison et al., "EFFECTS OF APOMORPHINE ON GLOBUS-PALLIDUS NEURONS IN PARKINSONIAN-PATIENTS", Annals of neurology, 42(5), 1997, pp. 767-775
55. SUAREZ JI; METMAN LV; REICH SG; DOUGHERTY PM; HALLETT M; LENZ FA
    PALLIDOTOMY FOR HEMIBALLISMUS - EFFICACY AND CHARACTERISTICS OF NEURONAL-ACTIVITY
    Annals of neurology
    
    J.I. Suarez et al., "PALLIDOTOMY FOR HEMIBALLISMUS - EFFICACY AND CHARACTERISTICS OF NEURONAL-ACTIVITY", Annals of neurology, 42(5), 1997, pp. 807-811
56. TAYLOR JR; ELSWORTH JD; ROTH RH; SLADEK JR; REDMOND DE
    SEVERE LONG-TERM METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-INDUCED PARKINSONISM IN THE VERVET MONKEY (CERCOPITHECUS-AETHIOPS SABAEUS)
    Neuroscience
    
    J.R. Taylor et al., "SEVERE LONG-TERM METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-INDUCED PARKINSONISM IN THE VERVET MONKEY (CERCOPITHECUS-AETHIOPS SABAEUS)", Neuroscience, 81(3), 1997, pp. 745-755
57. BEZARD E; BORAUD T; BIOULAC B; GROSS CE
    COMPENSATORY EFFECTS OF GLUTAMATERGIC INPUTS TO THE SUBSTANTIA-NIGRA PARS COMPACTA IN EXPERIMENTAL PARKINSONISM
    Neuroscience
    
    E. Bezard et al., "COMPENSATORY EFFECTS OF GLUTAMATERGIC INPUTS TO THE SUBSTANTIA-NIGRA PARS COMPACTA IN EXPERIMENTAL PARKINSONISM", Neuroscience, 81(2), 1997, pp. 399-404
58. PALERMONETO J
    DOPAMINERGIC SYSTEMS - DOPAMINE-RECEPTORS
    The Psychiatric clinics of North America
    
    J. Palermoneto, "DOPAMINERGIC SYSTEMS - DOPAMINE-RECEPTORS", The Psychiatric clinics of North America, 20(4), 1997, pp. 705
59. ALFAHELKAKUNDA A; SILVERMAN WF
    CALCIUM-BINDING PROTEINS IN THE SUBSTANTIA-NIGRA AND VENTRAL TEGMENTAL AREA DURING DEVELOPMENT - CORRELATION WITH DOPAMINERGIC COMPARTMENTALIZATION
    Developmental brain research
    
    A. Alfahelkakunda e W.F. Silverman, "CALCIUM-BINDING PROTEINS IN THE SUBSTANTIA-NIGRA AND VENTRAL TEGMENTAL AREA DURING DEVELOPMENT - CORRELATION WITH DOPAMINERGIC COMPARTMENTALIZATION", Developmental brain research, 103(1), 1997, pp. 9-20
60. FORNAI F; VAGLINI F; MAGGIO R; BONUCCELLI U; CORSINI GU
    SPECIES-DIFFERENCES IN THE ROLE OF EXCITATORY AMINO-ACIDS IN EXPERIMENTAL PARKINSONISM
    Neuroscience and biobehavioral reviews
    
    F. Fornai et al., "SPECIES-DIFFERENCES IN THE ROLE OF EXCITATORY AMINO-ACIDS IN EXPERIMENTAL PARKINSONISM", Neuroscience and biobehavioral reviews, 21(4), 1997, pp. 401-415
61. STARR MS; STARR BS; KAUR S
    STIMULATION OF BASAL AND L-DOPA-INDUCED MOTOR-ACTIVITY BY GLUTAMATE ANTAGONISTS IN ANIMAL-MODELS OF PARKINSONS-DISEASE
    Neuroscience and biobehavioral reviews
    
    M.S. Starr et al., "STIMULATION OF BASAL AND L-DOPA-INDUCED MOTOR-ACTIVITY BY GLUTAMATE ANTAGONISTS IN ANIMAL-MODELS OF PARKINSONS-DISEASE", Neuroscience and biobehavioral reviews, 21(4), 1997, pp. 437-446
62. BIGGS CS; STARR MS
    DOPAMINE AND GLUTAMATE CONTROL EACH OTHERS RELEASE IN THE BASAL GANGLIA - A MICRODIALYSIS STUDY OF THE ENTOPEDUNCULAR NUCLEUS AND SUBSTANTIA-NIGRA
    Neuroscience and biobehavioral reviews
    
    C.S. Biggs e M.S. Starr, "DOPAMINE AND GLUTAMATE CONTROL EACH OTHERS RELEASE IN THE BASAL GANGLIA - A MICRODIALYSIS STUDY OF THE ENTOPEDUNCULAR NUCLEUS AND SUBSTANTIA-NIGRA", Neuroscience and biobehavioral reviews, 21(4), 1997, pp. 497-504
63. LIU YJ; EDWARDS RH
    THE ROLE OF VESICULAR TRANSPORT PROTEINS IN SYNAPTIC TRANSMISSION ANDNEURAL DEGENERATION
    Annual review of neuroscience
    
    Y.J. Liu e R.H. Edwards, "THE ROLE OF VESICULAR TRANSPORT PROTEINS IN SYNAPTIC TRANSMISSION ANDNEURAL DEGENERATION", Annual review of neuroscience, 20, 1997, pp. 125-156
64. DOUDET DJ; CHAN GLY; HOLDEN JE; MORRISON KS; WYATT RJ; RUTH TJ
    EFFECTS OF CATECHOL-O-METHYLTRANSFERASE INHIBITION ON THE RATES OF UPTAKE AND REVERSIBILITY OF 6-FLUORO-L-DOPA TRAPPING IN MPTP-INDUCED PARKINSONISM IN MONKEYS
    Neuropharmacology
    
    D.J. Doudet et al., "EFFECTS OF CATECHOL-O-METHYLTRANSFERASE INHIBITION ON THE RATES OF UPTAKE AND REVERSIBILITY OF 6-FLUORO-L-DOPA TRAPPING IN MPTP-INDUCED PARKINSONISM IN MONKEYS", Neuropharmacology, 36(3), 1997, pp. 363-371
65. GRONDIN R; BEDARD PJ; BRITTON DR; SHIOSAKI K
    POTENTIAL THERAPEUTIC USE OF THE SELECTIVE DOPAMINE D-1 RECEPTOR AGONIST, A-86929 - AN ACUTE STUDY IN PARKINSONIAN LEVODOPA-PRIMED MONKEYS
    Neurology
    
    R. Grondin et al., "POTENTIAL THERAPEUTIC USE OF THE SELECTIVE DOPAMINE D-1 RECEPTOR AGONIST, A-86929 - AN ACUTE STUDY IN PARKINSONIAN LEVODOPA-PRIMED MONKEYS", Neurology, 49(2), 1997, pp. 421-426
66. OSTERTAG CB; LUCKING CH; MEHDORN HM; DEUSCHL G
    STEREOTAXIC TREATMENT OF MOVEMENT-DISORDE RS
    Nervenarzt
    
    C.B. Ostertag et al., "STEREOTAXIC TREATMENT OF MOVEMENT-DISORDE RS", Nervenarzt, 68(6), 1997, pp. 477-484
67. LOPEZLOZANO JJ; BRAVO G; BRERA B; MILLAN I; DARGALLO J; SALMEAN J; URIA J; INSAUSTI J; MARTINEZ R; DELATORRE C; MORENO R
    LONG-TERM IMPROVEMENT IN PATIENTS WITH SEVERE PARKINSONS-DISEASE AFTER IMPLANTATION OF FETAL VENTRAL MESENCEPHALIC TISSUE IN A CAVITY OF THE CAUDATE-NUCLEUS - 5-YEAR FOLLOW-UP IN 10 PATIENTS
    Journal of neurosurgery
    
    J.J. Lopezlozano et al., "LONG-TERM IMPROVEMENT IN PATIENTS WITH SEVERE PARKINSONS-DISEASE AFTER IMPLANTATION OF FETAL VENTRAL MESENCEPHALIC TISSUE IN A CAVITY OF THE CAUDATE-NUCLEUS - 5-YEAR FOLLOW-UP IN 10 PATIENTS", Journal of neurosurgery, 86(6), 1997, pp. 931-942
68. OBESO JA; GURIDI J; DELONG M
    SURGERY FOR PARKINSONS-DISEASE
    Journal of Neurology, Neurosurgery and Psychiatry
    
    J.A. Obeso et al., "SURGERY FOR PARKINSONS-DISEASE", Journal of Neurology, Neurosurgery and Psychiatry, 62(1), 1997, pp. 2-8
69. INGHAM CA; HOOD SH; MIJNSTER MJ; BALDOCK RA; ARBUTHNOTT GW
    PLASTICITY OF STRIATOPALLIDAL TERMINALS FOLLOWING UNILATERAL LESION OF THE DOPAMINERGIC NIGROSTRIATAL PATHWAY - A MORPHOLOGICAL-STUDY
    Experimental Brain Research
    
    C.A. Ingham et al., "PLASTICITY OF STRIATOPALLIDAL TERMINALS FOLLOWING UNILATERAL LESION OF THE DOPAMINERGIC NIGROSTRIATAL PATHWAY - A MORPHOLOGICAL-STUDY", Experimental Brain Research, 116(1), 1997, pp. 39-49
70. RICKARDS C; CODY FWJ
    PROPRIOCEPTIVE CONTROL OF WRIST MOVEMENTS IN PARKINSONS-DISEASE - REDUCED MUSCLE VIBRATION-INDUCED ERRORS
    Brain
    
    C. Rickards e F.W.J. Cody, "PROPRIOCEPTIVE CONTROL OF WRIST MOVEMENTS IN PARKINSONS-DISEASE - REDUCED MUSCLE VIBRATION-INDUCED ERRORS", Brain, 120, 1997, pp. 977-990
71. WICHMANN T; DELONG MR
    FUNCTIONAL AND PATHOPHYSIOLOGICAL MODELS OF THE BASAL GANGLIA
    Current opinion in neurobiology
    
    T. Wichmann e M.R. Delong, "FUNCTIONAL AND PATHOPHYSIOLOGICAL MODELS OF THE BASAL GANGLIA", Current opinion in neurobiology, 6(6), 1996, pp. 751-758
72. BLANCHET PJ; ALLARD P; GREGOIRE L; TARDIF F; BEDARD PJ
    RISK-FACTORS FOR PEAK DOSE DYSKINESIA IN 100 LEVODOPA-TREATED PARKINSONIAN-PATIENTS
    Canadian journal of neurological sciences
    
    P.J. Blanchet et al., "RISK-FACTORS FOR PEAK DOSE DYSKINESIA IN 100 LEVODOPA-TREATED PARKINSONIAN-PATIENTS", Canadian journal of neurological sciences, 23(3), 1996, pp. 189-193
73. NISBET AP; EVE DJ; KINGSBURY AE; DANIEL SE; MARSDEN CD; LEES AJ; FOSTER OJF
    GLUTAMATE DECARBOXYLASE-67 MESSENGER-RNA EXPRESSION IN NORMAL HUMAN BASAL GANGLIA AND IN PARKINSONS-DISEASE
    Neuroscience
    
    A.P. Nisbet et al., "GLUTAMATE DECARBOXYLASE-67 MESSENGER-RNA EXPRESSION IN NORMAL HUMAN BASAL GANGLIA AND IN PARKINSONS-DISEASE", Neuroscience, 75(2), 1996, pp. 389-406
74. MINK JW
    THE BASAL GANGLIA - FOCUSED SELECTION AND INHIBITION OF COMPETING MOTOR PROGRAMS
    Progress in neurobiology
    
    J.W. Mink, "THE BASAL GANGLIA - FOCUSED SELECTION AND INHIBITION OF COMPETING MOTOR PROGRAMS", Progress in neurobiology, 50(4), 1996, pp. 381-425
75. BASSO MA; POWERS AS; EVINGER C
    AN EXPLANATION FOR REFLEX BLINK HYPEREXCITABILITY IN PARKINSONS-DISEASE .1. SUPERIOR COLLICULUS
    The Journal of neuroscience
    
    M.A. Basso et al., "AN EXPLANATION FOR REFLEX BLINK HYPEREXCITABILITY IN PARKINSONS-DISEASE .1. SUPERIOR COLLICULUS", The Journal of neuroscience, 16(22), 1996, pp. 7308-7317
76. HARRINGTON KA; AUGOOD SJ; KINGSBURY AE; FOSTER OJF; EMSON PC
    DOPAMINE TRANSPORTER (DAT) AND SYNAPTIC VESICLE AMINE TRANSPORTER (VMAT2) GENE-EXPRESSION IN THE SUBSTANTIA-NIGRA OF CONTROL AND PARKINSONS-DISEASE
    Molecular brain research
    
    K.A. Harrington et al., "DOPAMINE TRANSPORTER (DAT) AND SYNAPTIC VESICLE AMINE TRANSPORTER (VMAT2) GENE-EXPRESSION IN THE SUBSTANTIA-NIGRA OF CONTROL AND PARKINSONS-DISEASE", Molecular brain research, 36(1), 1996, pp. 157-162
77. CHESSELET MF; DELFS JM
    BASAL GANGLIA AND MOVEMENT-DISORDERS - AN UPDATE
    Trends in neurosciences
    
    M.F. Chesselet e J.M. Delfs, "BASAL GANGLIA AND MOVEMENT-DISORDERS - AN UPDATE", Trends in neurosciences, 19(10), 1996, pp. 417-422
78. LIU Y; WAITES C; KRANTZ D; TAN P; EDWARDS RH
    MOLECULAR ANALYSIS OF NEUROTRANSMITTER TRANSPORT INTO SECRETORY VESICLES
    Cold Spring Harbor Symposia on Quantitative Biology
    
    Y. Liu et al., "MOLECULAR ANALYSIS OF NEUROTRANSMITTER TRANSPORT INTO SECRETORY VESICLES", Cold Spring Harbor Symposia on Quantitative Biology, 61, 1996, pp. 747-758
79. HERRERO MT; LEVY R; RUBERG M; LUQUIN MR; VILLARES J; GUILLEN J; FAUCHEUX B; JAVOYAGID F; GURIDI J; AGID Y; OBESO JA; HIRSCH EC
    CONSEQUENCE OF NIGROSTRIATAL DENERVATION AND L-DOPA THERAPY ON THE EXPRESSION OF GLUTAMIC-ACID DECARBOXYLASE MESSENGER-RNA IN THE PALLIDUM
    Neurology
    
    M.T. Herrero et al., "CONSEQUENCE OF NIGROSTRIATAL DENERVATION AND L-DOPA THERAPY ON THE EXPRESSION OF GLUTAMIC-ACID DECARBOXYLASE MESSENGER-RNA IN THE PALLIDUM", Neurology, 47(1), 1996, pp. 219-224
80. PIFL C; HORNYKIEWICZ O; GIROS B; CARON MG
    CATECHOLAMINE TRANSPORTERS AND 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE NEUROTOXICITY - STUDIES COMPARING THE CLONED HUMAN NORADRENALINE AND HUMAN DOPAMINE TRANSPORTER
    The Journal of pharmacology and experimental therapeutics
    
    C. Pifl et al., "CATECHOLAMINE TRANSPORTERS AND 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE NEUROTOXICITY - STUDIES COMPARING THE CLONED HUMAN NORADRENALINE AND HUMAN DOPAMINE TRANSPORTER", The Journal of pharmacology and experimental therapeutics, 277(3), 1996, pp. 1437-1443
81. CHERUEL F; DORMONT JF; FARIN D
    ACTIVITY OF NEURONS OF THE SUBTHALAMIC NUCLEUS IN RELATION TO MOTOR-PERFORMANCE IN THE CAT
    Experimental Brain Research
    
    F. Cheruel et al., "ACTIVITY OF NEURONS OF THE SUBTHALAMIC NUCLEUS IN RELATION TO MOTOR-PERFORMANCE IN THE CAT", Experimental Brain Research, 108(2), 1996, pp. 206-220
82. IACONO RP; LONSER RR; ULLOTH JE; SHIMA F
    POSTERO-VENTRAL PALLIDOTOMY IN PARKINSONS-DISEASE
    Journal of clinical neuroscience
    
    R.P. Iacono et al., "POSTERO-VENTRAL PALLIDOTOMY IN PARKINSONS-DISEASE", Journal of clinical neuroscience, 2(2), 1995, pp. 140-145
83. SCHUELER SB; SAGEN J; PAPPAS GD; KORDOWER JH
    LONG-TERM VIABILITY OF ISOLATED BOVINE ADRENAL-MEDULLARY CHROMAFFIN CELLS FOLLOWING INTRASTRIATAL TRANSPLANTATION
    Cell transplantation
    
    S.B. Schueler et al., "LONG-TERM VIABILITY OF ISOLATED BOVINE ADRENAL-MEDULLARY CHROMAFFIN CELLS FOLLOWING INTRASTRIATAL TRANSPLANTATION", Cell transplantation, 4(1), 1995, pp. 55-64
84. MITCHELL IJ; HUGHES N; CARROLL CB; BROTCHIE JM
    REVERSAL OF PARKINSONIAN SYMPTOMS BY INTRASTRIATAL AND SYSTEMIC MANIPULATIONS OF EXCITATORY AMINO-ACID AND DOPAMINE TRANSMISSION IN THE BILATERAL 6-OHDA LESIONED MARMOSET
    Behavioural pharmacology
    
    I.J. Mitchell et al., "REVERSAL OF PARKINSONIAN SYMPTOMS BY INTRASTRIATAL AND SYSTEMIC MANIPULATIONS OF EXCITATORY AMINO-ACID AND DOPAMINE TRANSMISSION IN THE BILATERAL 6-OHDA LESIONED MARMOSET", Behavioural pharmacology, 6(5-6), 1995, pp. 492-507
85. FROHNA PA; ROTHBLAT DS; JOYCE JN; SCHNEIDER JS
    ALTERATIONS IN DOPAMINE UPTAKE SITES AND D1 AND D2 RECEPTORS IN CATS SYMPTOMATIC FOR AND RECOVERED FROM EXPERIMENTAL PARKINSONISM
    Synapse
    
    P.A. Frohna et al., "ALTERATIONS IN DOPAMINE UPTAKE SITES AND D1 AND D2 RECEPTORS IN CATS SYMPTOMATIC FOR AND RECOVERED FROM EXPERIMENTAL PARKINSONISM", Synapse, 19(1), 1995, pp. 46-55
86. PEARCE RKB; JACKSON M; SMITH L; JENNER P; MARSDEN CD
    CHRONIC L-DOPA ADMINISTRATION INDUCES DYSKINESIAS IN THE METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-TREATED COMMON MARMOSET (CALLITHRIX-JACCHUS)
    Movement disorders
    
    R.K.B. Pearce et al., "CHRONIC L-DOPA ADMINISTRATION INDUCES DYSKINESIAS IN THE METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-TREATED COMMON MARMOSET (CALLITHRIX-JACCHUS)", Movement disorders, 10(6), 1995, pp. 731-740
87. BLANCHET PJ; GOMEZMANCILLA B; DIPAOLO T; BEDARD PJ
    IS STRIATAL DOPAMINERGIC RECEPTOR IMBALANCE RESPONSIBLE FOR LEVODOPA-INDUCED DYSKINESIA
    Fundamental and clinical pharmacology
    
    P.J. Blanchet et al., "IS STRIATAL DOPAMINERGIC RECEPTOR IMBALANCE RESPONSIBLE FOR LEVODOPA-INDUCED DYSKINESIA", Fundamental and clinical pharmacology, 9(5), 1995, pp. 434-442
88. BEDARD PJ; GOMEZMANCILLA B; BLANCHET P; GRONDIN R; DIPAOLO T
    DOPAMINE-RECEPTOR FAMILIES AND THE TREATMENT OF PARKINSONS-DISEASE
    Clinical neuropharmacology
    
    P.J. Bedard et al., "DOPAMINE-RECEPTOR FAMILIES AND THE TREATMENT OF PARKINSONS-DISEASE", Clinical neuropharmacology, 18, 1995, pp. 178-187
89. MATSUMURA M; TREMBLAY L; RICHARD H; FILION M
    ACTIVITY OF PALLIDAL NEURONS IN THE MONKEY DURING DYSKINESIA INDUCED BY INJECTION OF BICUCULLINE IN THE EXTERNAL PALLIDUM
    Neuroscience
    
    M. Matsumura et al., "ACTIVITY OF PALLIDAL NEURONS IN THE MONKEY DURING DYSKINESIA INDUCED BY INJECTION OF BICUCULLINE IN THE EXTERNAL PALLIDUM", Neuroscience, 65(1), 1995, pp. 59-70
90. PARENT A; COTE PY; LAVOIE B
    CHEMICAL ANATOMY OF PRIMATE BASAL GANGLIA
    Progress in neurobiology
    
    A. Parent et al., "CHEMICAL ANATOMY OF PRIMATE BASAL GANGLIA", Progress in neurobiology, 46(2-3), 1995, pp. 131
91. STARR MS
    ANTIPARKINSONIAN ACTIONS OF GLUTAMATE ANTAGONISTS - ALONE AND WITH L-DOPA - A REVIEW OF EVIDENCE AND SUGGESTIONS FOR POSSIBLE MECHANISMS
    Journal of neural transmission
    
    M.S. Starr, "ANTIPARKINSONIAN ACTIONS OF GLUTAMATE ANTAGONISTS - ALONE AND WITH L-DOPA - A REVIEW OF EVIDENCE AND SUGGESTIONS FOR POSSIBLE MECHANISMS", Journal of neural transmission, 10(2-3), 1995, pp. 141-185
92. KATO M; MIYASHITA N; HIKOSAKA O; MATSUMURA M; USUI S; KORI A
    EYE-MOVEMENTS IN MONKEYS WITH LOCAL DOPAMINE DEPLETION IN THE CAUDATE-NUCLEUS .1. DEFICITS IN SPONTANEOUS SACCADES
    The Journal of neuroscience
    
    M. Kato et al., "EYE-MOVEMENTS IN MONKEYS WITH LOCAL DOPAMINE DEPLETION IN THE CAUDATE-NUCLEUS .1. DEFICITS IN SPONTANEOUS SACCADES", The Journal of neuroscience, 15(1), 1995, pp. 912-927
93. JENNER P
    THE RATIONALE FOR THE USE OF DOPAMINE AGONISTS IN PARKINSONS-DISEASE
    Neurology
    
    P. Jenner, "THE RATIONALE FOR THE USE OF DOPAMINE AGONISTS IN PARKINSONS-DISEASE", Neurology, 45(3), 1995, pp. 6-12
94. BURBAUD P; GROSS C; BENAZZOUZ A; COUSSEMACQ M; BIOULAC B
    REDUCTION OF APOMORPHINE-INDUCED ROTATIONAL BEHAVIOR BY SUBTHALAMIC LESION IN 6-OHDA LESIONED RATS IS ASSOCIATED WITH A NORMALIZATION OF FIRING RATE AND DISCHARGE PATTERN OF PARS RETICULATA NEURONS
    Experimental Brain Research
    
    P. Burbaud et al., "REDUCTION OF APOMORPHINE-INDUCED ROTATIONAL BEHAVIOR BY SUBTHALAMIC LESION IN 6-OHDA LESIONED RATS IS ASSOCIATED WITH A NORMALIZATION OF FIRING RATE AND DISCHARGE PATTERN OF PARS RETICULATA NEURONS", Experimental Brain Research, 105(1), 1995, pp. 48-58
95. IACONO RP; LONSER RR; MAEDA G; KUNIYOSHI S; WARNER D; MANDYBUR G; YAMADA S
    CHRONIC ANTERIOR PALLIDAL STIMULATION FOR PARKINSONS-DISEASE
    Acta neurochirurgica
    
    R.P. Iacono et al., "CHRONIC ANTERIOR PALLIDAL STIMULATION FOR PARKINSONS-DISEASE", Acta neurochirurgica, 137(1-2), 1995, pp. 106-112
96. SANGHERA MK; MANAYE KF; LIANG CL; IACOPINO AM; BANNON MJ; GERMAN DC
    LOW DOPAMINE TRANSPORTER MESSENGER-RNA LEVELS IN MIDBRAIN REGIONS CONTAINING CALBINDIN
    NeuroReport
    
    M.K. Sanghera et al., "LOW DOPAMINE TRANSPORTER MESSENGER-RNA LEVELS IN MIDBRAIN REGIONS CONTAINING CALBINDIN", NeuroReport, 5(13), 1994, pp. 1641-1644
97. HUTCHISON WD; LOZANO AM; DAVIS KD; SAINTCYR JA; LANG AE; DOSTROVSKY JO
    DIFFERENTIAL NEURONAL-ACTIVITY IN SEGMENTS OF GLOBUS-PALLIDUS IN PARKINSONS-DISEASE PATIENTS
    NeuroReport
    
    W.D. Hutchison et al., "DIFFERENTIAL NEURONAL-ACTIVITY IN SEGMENTS OF GLOBUS-PALLIDUS IN PARKINSONS-DISEASE PATIENTS", NeuroReport, 5(12), 1994, pp. 1533-1537
98. BEVAN MD; BOLAM JP; CROSSMAN AR
    CONVERGENT SYNAPTIC INPUT FROM THE NEOSTRIATUM AND THE SUBTHALAMUS ONTO IDENTIFIED NIGROTHALAMIC NEURONS IN THE RAT
    European journal of neuroscience
    
    M.D. Bevan et al., "CONVERGENT SYNAPTIC INPUT FROM THE NEOSTRIATUM AND THE SUBTHALAMUS ONTO IDENTIFIED NIGROTHALAMIC NEURONS IN THE RAT", European journal of neuroscience, 6(3), 1994, pp. 320-334
99. RIDLEY RM; BAKER HF; ANNETT LE; DUNNETT SB; TORRES EM; FINE A
    BEHAVIORAL-ASSESSMENT OF THE ABILITY OF INTRACEREBRAL EMBRYONIC NEURAL TISSUE GRAFTS TO AMELIORATE THE EFFECTS OF BRAIN-DAMAGE IN MARMOSETS
    Molecular neurobiology
    
    R.M. Ridley et al., "BEHAVIORAL-ASSESSMENT OF THE ABILITY OF INTRACEREBRAL EMBRYONIC NEURAL TISSUE GRAFTS TO AMELIORATE THE EFFECTS OF BRAIN-DAMAGE IN MARMOSETS", Molecular neurobiology, 9(1-3), 1994, pp. 207-223
100. FILION M; TREMBLAY L; MATSUMURA M; RICHARD H
     DYNAMIC FOCUSING OF INFORMATIONAL CONVERG ENCE IN THE BASAL GANGLIA
     Revue neurologique
     
     M. Filion et al., "DYNAMIC FOCUSING OF INFORMATIONAL CONVERG ENCE IN THE BASAL GANGLIA", Revue neurologique, 150(8-9), 1994, pp. 627-633